Statement Of Changes In Equity [Abstract]

ERYTECH Pharma S.A. - Filing #880081

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through appropriation of retained earnings, equity
71 037 EUR
73 300 EUR
2 263 EUR
EUR
EUR
54 208 EUR
62 659 EUR
8 451 EUR
38 224 EUR
38 224 EUR
EUR
Increase (decrease) through conversion of convertible instruments, equity
14 400 EUR
Share issue related cost
3 811 EUR
3 811 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.